PT90743B - Processo para a preparacao de derivados de hirudina com accao retardada e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de derivados de hirudina com accao retardada e de composicoes farmaceuticas que os contem Download PDF

Info

Publication number
PT90743B
PT90743B PT90743A PT9074389A PT90743B PT 90743 B PT90743 B PT 90743B PT 90743 A PT90743 A PT 90743A PT 9074389 A PT9074389 A PT 9074389A PT 90743 B PT90743 B PT 90743B
Authority
PT
Portugal
Prior art keywords
lys
hirudin
gly
glu
process according
Prior art date
Application number
PT90743A
Other languages
English (en)
Portuguese (pt)
Other versions
PT90743A (pt
Inventor
Paul Habermann
Klaus Sauber
Dominique Tripier
Peter Crause
Martin Kramer
Rainer Obermeier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6355879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT90743(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT90743A publication Critical patent/PT90743A/pt
Publication of PT90743B publication Critical patent/PT90743B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/10—Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
PT90743A 1988-06-04 1989-06-02 Processo para a preparacao de derivados de hirudina com accao retardada e de composicoes farmaceuticas que os contem PT90743B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3819079A DE3819079A1 (de) 1988-06-04 1988-06-04 Hirudin-derivate mit verzoegerter wirkung

Publications (2)

Publication Number Publication Date
PT90743A PT90743A (pt) 1989-12-29
PT90743B true PT90743B (pt) 1994-10-31

Family

ID=6355879

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90743A PT90743B (pt) 1988-06-04 1989-06-02 Processo para a preparacao de derivados de hirudina com accao retardada e de composicoes farmaceuticas que os contem

Country Status (21)

Country Link
US (1) US5538946A (ko)
EP (1) EP0345616B1 (ko)
JP (1) JP2804514B2 (ko)
KR (1) KR0140884B1 (ko)
AT (1) ATE130315T1 (ko)
AU (1) AU625215B2 (ko)
CA (1) CA1340197C (ko)
CY (1) CY2025A (ko)
DE (2) DE3819079A1 (ko)
DK (1) DK175103B1 (ko)
ES (1) ES2080732T3 (ko)
FI (1) FI98703C (ko)
GR (1) GR3018364T3 (ko)
HK (1) HK1006024A1 (ko)
HU (1) HU204851B (ko)
IE (1) IE72201B1 (ko)
IL (1) IL90507A0 (ko)
NO (1) NO177312C (ko)
NZ (1) NZ229402A (ko)
PT (1) PT90743B (ko)
ZA (1) ZA894180B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2000887A1 (en) * 1988-11-01 1990-05-01 Cecilia S.L. Ku Thromboresistant materials and methods for making same
EP0502962B1 (de) * 1989-12-01 1996-03-13 BASF Aktiengesellschaft Hirudin-Muteine und deren Polyalkylenglykolkonjugate
JP2975632B2 (ja) * 1990-03-30 1999-11-10 生化学工業株式会社 グリコサミノグリカン修飾プロテイン
GB2247239A (en) * 1990-08-22 1992-02-26 Ciba Geigy Ag Hirudin conjugates with polyoxyethylene
DE4041185A1 (de) * 1990-12-21 1992-06-25 Knoll Ag Verwendung von hirudin und dessen muteinen zur kombinationsbehandlung von tumoren
DE4437502A1 (de) * 1993-12-02 1995-06-08 Basf Ag Hirudin-Konjugate aus Hirudin und lipophilen Verbindungen
DE4342154A1 (de) * 1993-12-10 1995-06-14 Behringwerke Ag Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19533817C2 (de) * 1995-09-13 1999-12-09 Max Planck Gesellschaft Komplex-gebundene Hemmstoffe aktivierbarer Stoffwechselenzyme als molekulare Marker zur Diagnostik und Therapieüberwachung
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6562781B1 (en) 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US5856452A (en) * 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
DE19915862A1 (de) * 1999-04-08 2000-10-12 Max Planck Gesellschaft Verwendung von molekulargewichtserweitertem Hirudin als Antikoagulans bei der extrakorporalen Nierenersatztherapie
US6809076B2 (en) * 2000-03-20 2004-10-26 Abbott Gmbh & Co. Kg Use of anticoagulant agents in the extracorporeal treatment of blood
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55500091A (ko) * 1978-02-17 1980-02-14
DE2930542A1 (de) * 1979-07-27 1981-02-12 Hoechst Ag Neue insulinderivate und verfahren zu ihrer herstellung
CA1341417C (fr) * 1984-03-27 2003-01-21 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
US4666884A (en) * 1984-04-10 1987-05-19 New England Deaconess Hospital Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
ATE64956T1 (de) * 1984-06-14 1991-07-15 Ciba Geigy Ag Verfahren zur herstellung von thrombininhibitoren.
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
DE3689525D1 (de) * 1985-07-17 1994-02-24 Hoechst Ag Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel.
DE3541856A1 (de) * 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens

Also Published As

Publication number Publication date
ZA894180B (en) 1990-02-28
HK1006024A1 (en) 1999-02-05
KR910001041A (ko) 1991-01-30
DK175103B1 (da) 2004-06-01
CY2025A (en) 1998-02-20
EP0345616B1 (de) 1995-11-15
FI98703B (fi) 1997-04-30
ES2080732T3 (es) 1996-02-16
EP0345616A3 (de) 1991-03-20
IE72201B1 (en) 1997-04-09
AU625215B2 (en) 1992-07-02
FI98703C (fi) 1997-08-11
JPH0267300A (ja) 1990-03-07
DE3819079A1 (de) 1989-12-07
DK270789A (da) 1989-12-05
KR0140884B1 (ko) 1998-06-15
NO177312B (no) 1995-05-15
FI892686A (fi) 1989-12-05
DE58909493D1 (de) 1995-12-21
DK270789D0 (da) 1989-06-02
AU3595589A (en) 1989-12-07
EP0345616A2 (de) 1989-12-13
HUT51298A (en) 1990-04-28
NO892267L (no) 1989-12-05
FI892686A0 (fi) 1989-06-01
NO177312C (no) 1995-08-23
GR3018364T3 (en) 1996-03-31
NO892267D0 (no) 1989-06-02
PT90743A (pt) 1989-12-29
HU204851B (en) 1992-02-28
CA1340197C (en) 1998-12-15
US5538946A (en) 1996-07-23
IL90507A0 (en) 1990-01-18
IE891815L (en) 1989-12-04
ATE130315T1 (de) 1995-12-15
NZ229402A (en) 1992-05-26
JP2804514B2 (ja) 1998-09-30

Similar Documents

Publication Publication Date Title
PT90743B (pt) Processo para a preparacao de derivados de hirudina com accao retardada e de composicoes farmaceuticas que os contem
US5256559A (en) Methods and compositions for inhibiting platelet aggregation
JP3701028B2 (ja) 高純度フォンビルブラント因子の入手方法
EP0333356A2 (en) Hirudin peptides
US5877153A (en) Heparin-binding peptides
AU623882B2 (en) Methods and compositions for inhibiting platelet aggregation
JPH0764875B2 (ja) 血液凝固阻害作用を有する新規ポリペプチド
JPS60136597A (ja) デスルフアトヒルジン、その製造及びそれを含む製薬組成物
JPS60136596A (ja) ペプチド及びこれを有効成分とする利尿剤
JPH06502624A (ja) 可溶性ヒルジン複合体
WO1991011458A1 (en) CYCLIC PEPTIDES CONTAINING Arg-Gly-Asp FLANKED BY PROLINE
WO1990003391A1 (en) Hirudin peptides
EP0999219A2 (en) Novel heparin binding peptides
JP2004506651A (ja) 抗ヘパリンペプチド
US5807982A (en) Affinity purified heparin
US6239101B1 (en) Thrombin binding polypeptides
FI104232B (fi) Hirudiinijohdannaisten käyttö trombiini-inhibiittoreina
WO1987000050A1 (en) Novel physiologically active substance having blood coagulation controlling activity
US5723576A (en) Thrombin inhibitors, the preparation thereof and the use thereof for therapeutical, prophylactic and diagnostic applications
JP5373077B2 (ja) ポリペプチド系物質、その製造方法、組織器官の虚血の予防用薬及び治療用薬
WO2007066179A2 (en) Peptides for antagonisation of anticoagulants and uses thereof
BG61670B2 (bg) Инхибитори на тромбина

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940412

PC3A Transfer or assignment

Free format text: 20010322 AVENTIS PHARMA DEUTSCHLAND GMBH DE

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20090602